Evidence map›Paper›PMID 40670800›Full record

ArticleNature2025

Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Uğur Şahin, Alexander Muik, Isabel Vogler, Evelyna Derhovanessian, Lena M Kranz, Mathias Vormehr, Jasmin Quandt, Nicole Bidmon, Alexander Ulges, Alina Baum and 39 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

49 authors.

Uğur ŞahinBioNTech, Mainz, Germany. Ugur.Sahin@biontech.de.ORCID http://orcid.org/0000-0003-0363-1564
Alexander MuikBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0003-4561-2273
Isabel VoglerBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0001-9757-9618
Evelyna DerhovanessianBioNTech, Mainz, Germany.
Lena M KranzBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0003-1943-3431
Mathias VormehrBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0001-7788-3380
Jasmin QuandtBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0001-9589-9941
Nicole BidmonBioNTech, Mainz, Germany.
Alexander UlgesBioNTech, Mainz, Germany.
Alina BaumRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Kristen E PascalRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.ORCID http://orcid.org/0000-0003-4826-4606
Daniel MaurusBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0003-2989-264X
Sebastian BrachtendorfBioNTech, Mainz, Germany.
Verena LörksBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0003-0673-9386
Julian SikorskiBioNTech, Mainz, Germany.
Peter KochBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0002-0638-0433
Rolf HilkerBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0002-8576-7731
Dirk BeckerBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0002-4786-9331
Ann-Kathrin EllerBioNTech, Mainz, Germany.
Jan GrütznerBioNTech, Mainz, Germany.
Manuel TonigoldBioNTech, Mainz, Germany.
Carsten BoeslerBioNTech, Mainz, Germany.
Corinna RosenbaumBioNTech, Mainz, Germany.
Ludwig HeesenBioNTech, Mainz, Germany.
Marie-Cristine KühnleBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0003-0256-5542
Asaf PoranBioNTech US, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-9118-1051
Jesse Z DongBioNTech US, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-4877-852X
Ulrich LuxemburgerBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0003-3505-3236
Alexandra Kemmer-BrückBioNTech, Mainz, Germany.
David LangerBioNTech, Mainz, Germany.
Martin BexonBexon Clinical Consulting LLC, Upper Montclair, NJ, USA.ORCID http://orcid.org/0000-0002-5361-4343
Stefanie BolteBioNTech, Mainz, Germany.
Tania PalancheBioNTech, Mainz, Germany.
Armin SchultzCRS Clinical Research Services Mannheim GmbH, Mannheim, Germany.
Sybille BaumannCRS Clinical Research Services Berlin GmbH, Berlin, Germany.
Azita J MahinyBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0001-9331-5869
Gábor BorosBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0002-8668-9800
Jonas ReinholzBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0003-2384-8541
Gábor T SzabóBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0001-9880-0425
Katalin KarikóBioNTech, Mainz, Germany.ORCID http://orcid.org/0000-0002-1864-3851
Pei-Yong ShiUniversity of Texas Medical Branch, Galveston, TX, USA.ORCID http://orcid.org/0000-0001-5553-1616
Camila Fontes-GarfiasUniversity of Texas Medical Branch, Galveston, TX, USA.ORCID http://orcid.org/0000-0002-1912-8413
John L PerezPfizer, Pearl River, NY, US.
Mark CutlerPfizer, Pearl River, NY, US.
David CooperPfizer, Pearl River, NY, US.
Christos A KyratsousRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.ORCID http://orcid.org/0000-0002-2596-2906
Philip R DormitzerPfizer, Pearl River, NY, US.ORCID http://orcid.org/0000-0003-0671-6360
Kathrin U JansenPfizer, Pearl River, NY, US.
Özlem TüreciBioNTech, Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40670800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.